Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery

NCT ID: NCT06671249

Last Updated: 2024-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

184 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-25

Study Completion Date

2027-10-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In recent years, laparoscopic breast cancer surgery has received wide attention. It has advantages of minimal invasiveness, clear anatomical exposure, and good aesthetic effects. Based on these advantages, we propose whether laparoscopy is suitable for breast-conserving surgery for breast cancer. The standard procedure of laparoscopic breast-conserving surgery is unclear. More high-quality clinical studies are required. Therefore, we intend to conduct a multi-center, open, productive, randomized controlled study comparing the safety and cosmetic effects of endoscopic breast-conserving with traditional open breast-conserving surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In recent years, laparoscopic breast cancer surgery has received wide attention. It has advantages of minimal invasiveness, clear anatomical exposure, and good aesthetic effects. Based on these advantages, we propose whether laparoscopy is suitable for breast-conserving surgery for breast cancer. The standard procedure of laparoscopic breast-conserving surgery is unclear. More high-quality clinical studies are required to ensure the efficiency of cure. Also, less scars and breast preservation has becoming more and more important for patients' acceptance to the treatment. Therefore, we intend to conduct a multi-center, open, productive, randomized controlled study comparing the safety and cosmetic effects of endoscopic breast-conserving with traditional open breast-conserving surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Laparoscopic breast-conserving surgery

Subjects who is going to accept laparoscopic breast-conserving surgery.

Group Type EXPERIMENTAL

Laparoscopic breast-conserving surgery

Intervention Type PROCEDURE

Use laparoscopic surgery to treat breast cancer patients who want and have the opportunity to preserve their breast

Traditional open breast-conserving surgery

Subjects who is going to accept traditional open breast-conserving surgery.

Group Type ACTIVE_COMPARATOR

Traditional open breast-conserving surgery

Intervention Type PROCEDURE

Treat breast cancer patients who want and have the opportunity to preserve their breast with traditional open breast-conserving surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic breast-conserving surgery

Use laparoscopic surgery to treat breast cancer patients who want and have the opportunity to preserve their breast

Intervention Type PROCEDURE

Traditional open breast-conserving surgery

Treat breast cancer patients who want and have the opportunity to preserve their breast with traditional open breast-conserving surgery.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female over the age of 18
* Preoperative pathologically confirmed invasive breast cancer or ductal carcinoma in situ
* Clinical classification T1, T2 (maximum tumor diameter ≤5cm)
* Single-center tumor (preoperative confirmation by B-ultrasound, MRI and other imaging examinations)
* No clinical or imaging evidence of distant metastasis
* Able and willing to sign informed consent

Exclusion Criteria

* Tumor in the lower inner quadrant
* Tumor in multiple quadrants
* Imaging or intraoperative pathology indicates tumor invasion of the nipple areola, skin, or pectoralis major
* Locally advanced breast cancer patients are undergoing neoadjuvant therapy
* Tumor in multiple quadrants
* Have been participating in other clinical trials, which may affect the participation in this trial
* Previous history of breast cancer (patients with recurrence after ipilateral breast-conserving surgery)
* Pregnant and lactating women
* Patients with severe cardiopulmonary disease or severely impaired lung function are not suitable for surgical establishment of an air cavity
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xiaochen - Wang, Doctorate

Role: PRINCIPAL_INVESTIGATOR

Second Affiliated Hospital, School of Medicine, Zhejiang University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xiaochen Wang

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Xiaochen - Wang, Doctorate

Role: CONTACT

+86 13958161286

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiaochen - Wang, Doctorate

Role: primary

+86 13958161268

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-1251

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.